Kevin O'Neill Joins The CECON Group

Share Article

Kevin O'Neill is a Program and Market Manager at The CECON Group

News Image

Kevin O'Neill, Program and Market Manager at The CECON Group

Our clients require expert consultants with very specific scientific or engineering expertise. Kevin's knowledge and experience will be very beneficial to our clients.

The CECON Group is pleased to announce that it has hired Kevin O’Neill for the position of Program and Market Manager for its life sciences markets. In this role, he will work with clients and consultants to implement and manage consulting projects.

CECON Program Managers use their technical and industry experience to conduct custom searches and leverage the CECON network of consultants to locate, vet, and recommend scientific and engineering experts for each client’s consideration.

Mr. O’Neill has over 20 years of global experience in the commercialization of pharmaceutical products in launch, mid- or late-cycle, and specializes in vaccines, anti-infectives, diabetes and cardiovascular therapeutic categories.

Previously, Mr. O’Neill held the position of Vice President at Pfizer Pharmaceuticals (formerly Wyeth) in the Vaccines division, where he contributed to the success of Pfizer’s industry-leading Prevenar pediatric and adult vaccine business.

Commenting on the appointment, CECON President Mike Fisher said, “Our clients require expert consultants with very specific scientific or engineering expertise. Kevin’s knowledge and experience in life sciences will be very beneficial to our clients in understanding the scope and nature of their projects.

Kevin O’Neill holds a B.S. in Biology from Ursinus College in Pennsylvania. He is a board member and coach for the Phoenixville Area Soccer Club and volunteers for the Boy Scouts of America.

Founded in 1985, The CECON Group specializes in providing science and engineering consultants and expert witnesses. Consultants in their global network typically have more than 25 years of experience in more than 200 disciplines, including pharmaceutical development and regulatory compliance, chemical processing and safety, biotechnology, medical devices, nanotechnology, and polymers and coatings.

For more information, visit or call 888-263-8000.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Charlotte Zang
+1 (410) 810-8862
Email >
Visit website